Catarina M. Alves
Porto, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Discovery of Novel Ligands for the Treatment of Cryptococcus neoformans Infection.
Journal: Archiv der Pharmazie
Published: March 11, 2026
Suspected Sources of Infection and Transmission Factors Associated With Campylobacteriosis in Northern Portugal.
Journal: Zoonoses and public health
Published: September 03, 2024
Is it worth screening quarry workers for TB infection in high-incidence areas? A cost-benefit analysis.
Journal: Respiratory medicine
Published: May 03, 2024
Community-Based Action Research Intervention to Promote Occupational Health Nursing of Portuguese Quarry Workers.
Journal: Nursing reports (Pavia, Italy)
Published: October 27, 2023
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: August 26, 2023
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta-analysis.
Journal: United European gastroenterology journal
Published: October 05, 2022
Impact of Crohn's Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis.
Journal: Inflammatory bowel diseases
Published: June 14, 2022
Composite outcomes in observational studies of Crohn's disease: a systematic review and meta-analysis.
Journal: Therapeutic advances in gastroenterology
Published: November 24, 2021
Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysis.
Journal: United European gastroenterology journal
Published: September 25, 2021
The Magnitude of Crohn's Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review.
Journal: Inflammatory bowel diseases
Published: September 14, 2021
Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 02, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort Study.
Journal: Journal of clinical medicine
Published: May 27, 2021
Last Updated: 09/26/2026